Hear expert insight from Abzena’s CTO on how to de-risk and streamline the development of your biopharmaceutical in order to successfully meet your next regulatory or clinical milestone.

EirGenix has immediate availability of capacity up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial and that will increase to 350L and 1,000L by end of this year.

Learn how FDB enables the ability to go from small to large scale as their product demand increases and is fostering alignment across their large scale sites at an unprecedented level in the industry.

Learn how KBI Biopharma is equipped to support drug development and biologics manufacturing and accelerate your timeline.

Explore Mabion's new installations in upstream development, bioreactors, and downstream development and fill finish.

As we expand our mammalian capacity across the manufacturing network, updates on completion dates and capacity availability are presented in the session.

With a strong network of sites, Resilience provides innovative solutions and services for established and emerging therapies. Learn how we can support your development and manufacturing programs.

Simtra currently has open capacity for liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project and the availability of materials.

In this presentation from the February 2024 OPCU event, discover Singota’s capabilities in providing formulation development, analytical development, aseptic manufacturing, and supply chain services.

Explore the recent expansions of Ajinomoto BPS. Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late-stage projects.

Cambrex offers strong expertise in custom development and cGMP API manufacturing for small molecules, including HPAPI, through its Charles City, Iowa facility.

Discover Nanoform’s manufacturing capabilities, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients.

Societal provides development, regulatory support, clinical and commercial manufacturing, packaging, and logistics services. Delve into Societal’s capabilities and open capacity across sites.

In this presentation from the February 2024 OPCU event, learn more about the AGC Biologics’ global Cell and Gene network, track record, capabilities, and how it can provide support for any project.

Examine Aldevron's custom manufacturing services and ready-for-use products to support your pipeline and review our new capacity for cGMP RNP manufacturing to streamline CRISPR gene editing programs.

Learn more about BioCentriq's state-of-the-art facilities, established track record in GMP drug product release, and customized solutions supported by a seasoned team with strong commitment to quality.

Explore our facility as we share how our ecosystem brings together R&D, cGMP manufacturing, and groundbreaking technologies to help enhance speed, delivery, and probability of success to support CGTs.

Explore Forge’s 200,000 square foot, custom-designed cGMP facility dedicated to AAV and plasmid manufacturing.

Following FUJIFILM's recent investment in cell therapy services, this presentation offers a glimpse into the flexible, smart designs included in the capacity expansion at the Thousand Oaks facility.

Gain an overview of the CGT manufacturing services provided by Novartis Contract Manufacturing and how the in-house capabilities within our network can support clients' needs in end-to-end production.